Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of bioAffinity Technologies (NASDAQ:BIAF) through any online brokerage.
Other companies in bioAffinity Technologies’s space includes: Alzamend Neuro Inc (NASDAQ:ALZN), Immuron Ltd (NASDAQ:IMRN), Acurx Pharmaceuticals Inc (NASDAQ:ACXP), Quoin Pharmaceuticals Ltd (NASDAQ:QNRX) and Genprex Inc (NASDAQ:GNPX).
There is no analysis for bioAffinity Technologies to provide a consensus price target.
The stock price for bioAffinity Technologies (NASDAQ: BIAF) is $1.5 last updated December 15, 2025 at 9:01 AM EST.
There are no upcoming dividends for bioAffinity Technologies.
bioAffinity Technologies does not have any upcoming earnings scheduled.
There is no upcoming split for bioAffinity Technologies.
bioAffinity Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.